💥On behalf of co-investigators @claretempany @adamkibel_uro @qdtrinh and co-senior authors @geoffsonn Peji Ghanouni, we are excited to share the FINAL results of MR-guided HIFU Focal Therapy in men with intermediate risk prostate cancer. 1/8 thelancet.com/journals/lanon…

Thanks @urogoldjournal for publishing our work on MRI-targeted biopsy for suspected local recurrence after RP. Biopsy prior to salvage RT (esp in equivocal cases) can guide dose escalation strategies @BehfarEhdaieMD @BCottaMD @HimanshuNagarMD @UrologyMSK goldjournal.net/article/S009…

Can't make it to SUO? Don't worry, @MedStarHealth has you covered! Join us in DC in October for Advances in Urologic Oncology 2026, our biannual, high-impact, two-day review of the latest advances in our field. Confirmed speakers so far: @wandering_gu, @jimhumd, @daviesbj, @arvinkgeorge, @BehfarEhdaieMD, @rovingatuscap, @NitinYerram, @egan_jillian26, @akfsurgeon, @brian_rini, and more to come! A good time is guaranteed! Register here: medstar.cloud-cme.com/course…

This is what I'm talking about @ #AUA26: The masters at focal therapy discuss the finer points at the "Essentials in Prostate Cancer Focal Therapy" Course. The field is maturing and it great to see data driven decision making to optimize care for our pts with prostate cancer.

@BehfarEhdaieMD Kicking off the @UrologyMSK focal therapy and targeted biopsy course @KoelisBx @FocalOneHIFU

Honored to join Urologic Oncology colleagues and lend a Pathology voice and insights to the proceedings of this meeting addressing Targeted Biopsy & Focal Therapy @BehfarEhdaieMD @MSKCancerCenter

🎯 Join us at @MSKCancerCenter for Advanced Techniques in Target Prostate Biopsy & Focal Therapy in Prostate Cancer Case-based interactive expert panels 📅 05/14/26 @ NYC 🗽🇺🇸 Perfect timing before heading to DC for #AUA2026 ✈️ 🚅 Free registration 🔗: mskcc.cloud-cme.com/course/c…

Come join us for hopefully an engaging and balanced AUA Course reviewing key concepts in prostate cancer focal therapy. Distinguished faculty discuss their experience and reveal advanced techniques using all focal therapy technology in a lively case-based format #AUA25

The inaugural Masterclass in Robotic HIFU for Prostate Cancer is only one day away! We are excited to have focal therapy experts Pierre Halteh, MD, @AmirLebastchi, MD, @BehfarEhdaieMD and Pr. Sebastien Crouzet share their personal experience. @USC_Urology @FocalOneHIFU

Now in Clin Genitourin Cancer by @UrologyMSK @SigridCarlsson @vinlaudonemd @TouijerKarim @easthamja @BehfarEhdaieMD et al: Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Grade Group 2 Prostate Cancer on Active Surveillance sciencedirect.com/science/ar…

#GU Reporting Insights: #ProstateCancer Program Covers: 1) prework talks (now available online) and 2) live-streamed webinar on Jan 22, 2025. Please register and share! Big discounts for junior CAP members! #GUPath #Pathology 👇👇👇 education.cap.org/node/12787

Is it possible to conduct large randomized surgical clinical trials in a single institution? The answer is yes, say Andrew Vickers and colleagues, reporting their experiences at Memorial Sloan Kettering. @SCTorg @VickersBiostat @MSKCancerCenter @MSKBiostats @BehfarEhdaieMD

#SUO24 #Debate – Management of localized radiorecurrent #ProstateCancer: Salvage radical prostatectomy. Presentation by @BehfarEhdaieMD @MSKCancerCenter. Written coverage by @zklaassen_md @GACancerCenter > bit.ly/3VteScK @UroOnc

Come join us for hopefully an engaging and balanced AUA Course reviewing the role of focal therapy in prostate cancer & translating the outcomes of clinical trials in clinical practice. Agnostic of technology but esteemed faculty discussing experience with all FT devices. #AUA24

GUPS companion meeting at USCAP is almost here!

“Lu”tectomy using Lu-PSMA + Radical Prostatectomy is feasible and reports a signal for response in Phase I study. Novel work from @PeterMacCC @RenuEapen @declangmurphy #KPS2024

Wonderful invitation to exchange ideas at the International Prostate Cancer meeting in Seoul, Korea. PSA testing low in Korea due to low social perception of risk. However, risk of prostate cancer in Korea continues to rise!

4 Weeks from TODAY!! Join the @GU_Path_Society Companion Society Meeting #USCAP2024 featuring: Dr. Sean Williamson @Williamson_SR Dr. Francesca Khani @FKhaniPath Dr. Behfar Ehdaie @BehfarEhdaieMD Moderated by: @LotanLab @FionaMacPath #gupath #UroSoMe